CROs/Service Providers

LakePharma partners with Ampersand, acquires Blue Sky BioServices

Wednesday, March 30, 2016

LakePharma, a provider of integrated solutions covering the biologics CRO space, has acquired Blue Sky BioServices, a CRO specializing in protein and antibody production and assay services. The combined company will be known as LakePharma, and is now the largest dedicated biologics CRO in the U.S., providing a broad range of protein and antibody-related development services to the pharmaceutical and biotechnology markets. Blue Sky BioServices is a portfolio company of Ampersand Capital Partners and as part of the transaction, Ampersand made an investment into LakePharma to support growth initiatives. 

[Read More]

WuXi AppTec launches South Korea Branch

Monday, March 28, 2016

WuXi AppTec, an open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, has opened its branch office in Seoul, South Korea, one of the most dynamic life science innovation hubs in the Asia Pacific region.

[Read More]

BioPharmaSpec expands into Asia

Thursday, March 24, 2016

BioPharmaSpec, a CRO providing a full range of characterization services for the biotechnology industry, is expanding its business in Asia with business development teams in India and the Asia Pacific region. This will allow scientists in the region to access BioPharmaSpec’s cost-effective, efficient characterization strategies and help accelerate the development of their biosimilars.

[Read More]

Covance launches Mobile Health Solutions

Thursday, March 17, 2016

Laboratory Corporation of America Holdings (LabCorp) has announced that Covance Drug Development has launched Mobile Health Solutions, a suite of new capabilities designed to help biopharmaceutical and technology companies navigate the rapidly evolving mobile health landscape. Covance’s Mobile Health Solutions suite provides regulatory consulting and validation services to help companies certify the accuracy and consistency of mobile devices and applications for use in clinical trials.

[Read More]

CROs juggle proprietary and commercial systems

Tuesday, March 15, 2016

Third-party vendors have come to dominate the clinical trial technology sector, which was led by CROs a decade ago. At the same time, many large CROs continue to invest in technology solutions to differentiate their services and offer greater efficiencies in clinical development processes.

[Read More]

Almac opens companion diagnostic laboratory in North Carolina

Thursday, March 10, 2016

Almac Group’s Diagnostics Business Unit has opened a new companion diagnostic development facility located in the Research Triangle Park region of North Carolina. The North Carolina facility will provide a U.S. base to support Almac’s increased demand for its CDx development partnerships as well as a CLIA-accredited laboratory to support the downstream delivery of assays for patient testing.

[Read More]

Clintrax Global joins WIRB-Copernicus Group

Thursday, March 10, 2016

Clintrax Global has joined the WIRB-Copernicus Group (WCG) family of companies. WCG is a leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that. Founded by former biopharmaceutical and CRO attorneys, Clintrax Global provides outsourced services for negotiating clinical trial-related contracts and budgets between biopharmaceutical companies, CROs and investigator sites around the world. Clintrax Global also manages, executes, and tracks payments between these global clinical trial participants.

[Read More]